Biblio
Toward an optimal global stem cell donor recruitment strategy. PLoS One. 2014;9(1):e86605.
. Stem cell donor registry activities during the COVID-19 pandemic: a field report by DKMS. Bone Marrow Transplant. 2020.
Small volume bone marrow aspirates with high progenitor cell concentrations maximize cell therapy dose manufacture and substantially reduce donor hemoglobin loss. BMC Med. 2023;21(1):360.
Regional HLA Differences in Poland and Their Effect on Stem Cell Donor Registry Planning. PLoS One. 2013;8(9):e73835.
. Reanalysis of unclear CMV status results from buccal swab samples of potential stem cell donors is an efficient donor registry strategy. Transpl Immunol. 2022:101729.
Providing hematopoietic stem cell products from unrelated donors to the world: DKMS donor centers and DKMS Registry. Best Pract Res Clin Haematol. 2024;37(1):101541.
. Non-invasive determination of CMV serostatus from dried buccal swab samples: assay development, validation and application to 1.2 million samples. J Infect Dis. 2020.
. Introduction of principles of blood management to healthy donor bone marrow harvesting. Vox Sang. 2020.
Immunogenetics in stem cell donor registry work: The DKMS example (Part 2). Int J Immunogenet. 2020.
HLA allele and haplotype frequencies of registered stem cell donors in Chile. Front Immunol. 2023;14:1175135.
. Donor genotype based outcome prediction after allogeneic stem cell transplantation: no land in sight. Front Immunol. 2024;15:1350470.
Cryopreservation for all is no option in unrelated stem cell transplantation (Comment to: Dholaria B, et al. Securing the graft during pandemic: are we ready for cryopreservation for all? Biol Blood Marrow Transplant. 2020;26(7):e145-e146.). Biol Blood Marrow Transplant. 2020.
. CCR5Δ32 mutations do not determine COVID-19 disease course. Int J Infect Dis. 2021.
. 5 years DKMS Chile: approach, results and impact of the first unrelated stem cell donor center in Chile. Front Med (Lausanne). 2023;10:1236506.